Available Forms: Tablets, Capsules
Available Strengths: 50 mg , 250 mg
Reference Brands: Mysoline (USA)
Category: Neurology
Quick Response Guaranteed | Verified Suppliers
Product Description:
Primidone is an aromatic anticonvulsant medication that plays an important role in the long-term management of epilepsy and related seizure disorders. It has been in clinical use for several decades and remains a valuable therapeutic option for patients who require effective seizure control, either as monotherapy or in combination with other antiepileptic drugs. Primidone is particularly useful in the treatment of generalized tonic-clonic seizures and partial seizures, including simple and complex partial seizures, and it also has documented efficacy in myoclonic seizures. In certain epilepsy subtypes, such as juvenile myoclonic epilepsy, primidone is considered a second-line therapy and is typically reserved for patients who do not respond adequately to first-line agents such as valproates or lamotrigine.
Pharmacologically, primidone exerts its antiepileptic effects through its active metabolites, phenobarbital and phenylethylmalonamide (PEMA). These metabolites contribute significantly to its therapeutic activity by enhancing inhibitory neurotransmission within the central nervous system and reducing abnormal neuronal firing. Through these mechanisms, primidone helps stabilize neuronal membranes and suppress the excessive electrical discharges responsible for seizure activity. The gradual formation of active metabolites also explains the need for careful dose titration and monitoring during therapy.
Primidone is used to treat epilepsy, particularly generalized tonic-clonic seizures and focal (partial) seizures. It is also widely prescribed for the management of essential tremor when first-line therapies are not effective or suitable.
Primidone is a synthetic anticonvulsant compound belonging to the barbiturate-related class of antiepileptic drugs. In the body, it is metabolized into phenobarbital and phenylethylmalonamide (PEMA), which contribute to its therapeutic effect.
Primidone is commonly marketed under the trade name Mysoline.
The original branded product Mysoline was developed and marketed by Wyeth. Today, primidone is manufactured and supplied by multiple generic pharmaceutical companies worldwide.
The complete generic name is primidone.
The well-known brand name of primidone is Mysoline.
Primidone is manufactured in several countries, including the USA, UK, and EU member states, by different approved pharmaceutical manufacturers for global distribution.
Strength: 125 mg/mL, 200 mg, 250 mg, 300 mg, 500 mg, 100 mg/mL
Form: Tablet / Capsule/ Injection / Oral syrup
Reference Brands: Depakene (USA), Depakine (EU/LATAM), Valprol (India)
Strength: 50 mg, 100 mg
Form: Tablets
Reference Brands: Ubrelvy (USA/India)
Strength: 100 mg
Reference Brands: Tasmar (USA/EU)
Strength: 50 mg ,100 mg
Reference Brands: Xadago (USA/EU)
By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under βFair use.β
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Stay updated on pharma trends and marketplace opportunities.
Online Β· B2B Pharma Β· Medical Tourism Β· NPP